01 Growing Adoption of Dual-Modality Intravascular Imaging Catheters The catheter market is advancing toward multifunctional imaging devices that combine complementary visualization technologies within a single catheter. Integrating intravascular ultrasound with high-resolution optical imaging allows physicians to assess both deeper vessel structures and detailed surface characteristics without exchanging separate imaging devices. This can simplify coronary procedures while improving information available for treatment planning. Multi-sensor imaging technology is therefore becoming an important part of catheter market trends. In October 2025, Terumo received FDA 510(k) clearance for its DualView imaging catheter, which combines OFDI and IVUS imaging. The catheter provides a maximum pullback length of 150 mm, a 2.6 Fr imaging profile, 6 Fr guide compatibility, and pullback speeds reaching 40 mm per second.
02 Increasing Development of Catheters for Pulsed Field Ablation Cardiac electrophysiology is increasingly adopting pulsed field ablation, creating demand for specialized catheters capable of delivering controlled electrical fields to cardiac tissue. Unlike conventional thermal ablation, PFA uses short electrical pulses to selectively affect targeted cells, potentially reducing damage to surrounding structures. Catheters that combine mapping and ablation can further simplify electrophysiology workflows. PFA-focused development is consequently expanding the catheter industry toward advanced treatment of cardiac arrhythmias. In January 2025, Medtronic reported continued commercial expansion of its Sphere-9 catheter with the Affera Mapping and Ablation System. The Sphere-9 integrates high-density mapping with both pulsed-field and radiofrequency ablation through a single 9 mm lattice-tip catheter.
01 Growing Need for Advanced Atrial Fibrillation Treatment Atrial fibrillation is increasing the requirement for catheter-based procedures capable of identifying and treating abnormal electrical pathways within the heart. Modern ablation catheters provide greater control over energy delivery and tissue contact, helping physicians perform increasingly sophisticated electrophysiology procedures. As catheter ablation becomes more widely used for rhythm management, demand for specialized devices continues to increase. Expansion of interventional arrhythmia treatment is therefore strengthening catheter market demand.
01 Complex Regulatory Requirements Increase Product Development Burden Catheters used in invasive cardiovascular, neurovascular, and other procedures must undergo extensive design validation, biocompatibility assessment, sterilization testing, performance evaluation, and regulatory review. Manufacturers must demonstrate that new devices are sufficiently safe and effective before commercialization, while design modifications may trigger additional regulatory requirements. These processes increase development costs and can delay market entry. Regulatory complexity can consequently restrain catheter market growth, particularly for smaller manufacturers developing specialized devices.
01 Expansion of Catheter-Based Treatment for Calcified Coronary Arteries Severely calcified coronary lesions create an opportunity for specialized catheters that modify calcium before angioplasty or stent implantation. Intravascular lithotripsy delivers mechanical energy through a catheter to fracture calcium while limiting trauma to surrounding soft tissue. Increasing treatment of complex coronary disease can therefore expand demand for dedicated lesion-preparation devices. This application provides manufacturers with an opportunity to increase catheter market share through advanced coronary interventions.
01 Maintaining Reliable Central Venous Access in Patients With Venous Obstruction Repeated dialysis, chemotherapy, and other long-term therapies can cause central veins to narrow or become obstructed, making conventional catheter placement increasingly difficult. Clinicians must establish vascular access while avoiding complications and preserving remaining veins for future treatment. Specialized access systems therefore need sufficient navigation capability and procedural control to cross challenging anatomy safely. Managing complex venous obstruction remains a significant technical challenge as catheter market size expands across patients requiring repeated vascular access.
May 2026 BD (Becton, Dickinson and Company) expanded its catheter portfolio by introducing advanced vascular access solutions featuring improved safety mechanisms, antimicrobial technologies, and enhanced patient care capabilities.
March 2026 Teleflex expanded its Arrow® catheter product portfolio with new vascular access technologies designed to improve infection prevention, procedure efficiency, and clinical outcomes.
December 2025 Boston Scientific launched upgraded catheter-based medical devices incorporating advanced materials and precision technologies for cardiovascular, urology, and minimally invasive procedures.
September 2025 Medtronic expanded its catheter-based therapy portfolio by introducing new minimally invasive solutions for cardiovascular and structural heart procedures.